Precision medicine in diabetic nephropathy and chronic kidney disease

Link to article at PubMed

Nephrol Dial Transplant. 2021 Jun 22;36(Supplement_2):10-13. doi: 10.1093/ndt/gfaa380.

ABSTRACT

Progressive chronic kidney disease (CKD) in individuals with type 2 diabetes mellitus is a global public health problem accompanied by substantial comorbidities and reduced life expectancy. In this respect, CKD leading to uremia can be seen as a systemic disease with a critical impact on virtually all organ systems. Thus it is of particular importance to identify patients with incipient CKD and ongoing CKD progression, but the individual course of CKD is challenging to predict. Patterns of progression in persons with CKD include linear and nonlinear trajectories of glomerular filtration rate (GFR) loss. Kidney function can also remain stable for years, especially in the elderly. In particular, one-fifth of individuals show a substantial GFR decline in the absence of high albuminuria (nonproteinuric CKD), rendering albuminuria less suitable for predicting the progression in such individuals.

PMID:34153982 | DOI:10.1093/ndt/gfaa380

Leave a Reply

Your email address will not be published.